The role of serotonin in panic: Evidence from tryptophan depletion studies

Acta Neuropsychiatrica

Volumn 16, Issue 2, 2004, Pages 79-84

  Pyle, A C ^b   Argyropoulos, S V ^b   Nutt, D J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

Panic; Serotonin; Trytophan depletion

Indexed keywords

SEROTONIN; TRYPTOPHAN;

ANXIETY; BLOOD BRAIN BARRIER; HUMAN; MOOD; NEUROBIOLOGY; NEUROTRANSMISSION; PANIC; REVIEW;

EID: 1642544540     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0924-2708.2004.0081.x     Document Type: Review

References (40)

1. BELL CJ, NUTT DJ. Serotonin and panic. Br J Psychiatry 1998;172:465-471.
2. DEAKIN JF, GRAEFF F. 5-HT and mechanisms of defence. J Psychopharmacol 1991;5:305-315.
3. NUTT DJ, GLUE P. Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmacol Ther 1989;44:309-334.
4. HANDLEY SL, McBLANE JW, CRITCHLEY MA, NJUNG EK. Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav Brain Res 1993;58:203-210.
5. DEN BOER JA, WESTENBERG HG. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 1990;102:85-94.
6. DEN BOER JA. Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint. J Clin Psychiatry 1998;59(Suppl. 8):30-36.
7. VALENCA AM, NARDI AE, NASCIMENTO I, MEZZASALMA MA, LOPES FL, ZIN W. Double-blind clonazepam vs placebo in panic disorder treatment. Arq Neuropsiquiatr 2000;58:1025-1029.
8. ARGYROPOULOS SV, SANDFORD JJ, NUTT DJ. The psychobiology of anxiolytic drug. Part 2. Pharmacological treatments of anxiety. Pharmacol Ther 2000;88:213-227.
9. KASPER S, RESINGER E. Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. Eur Neuropsychopharmacol 2001;11:307-321.
10. BOYER W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995;10:45-49.
11. NUTT DJ, COWEN PJ. Benzodiazepine-serotonin interactions in man. Psychopharmacol Series 1987;3:72-76.
12. TORK I. Anatomy of the serotonergic system. Ann NY Acad Sci 1990;600:9-34.
13. PIKE VW, MCCARRON JA, LAMMERSTMA AA et al. First delineation of 5-HTIA receptors in human brain with PET and [11C]WAY-100635. Eur J Pharmacol 1995;283:R1-R3.
14. TAUSCHER J, BAGBY RM, JAVANMARD M, CHRISTENSEN BK, KASPER S, KAPUR S. Inverse relationship between serotonin 5-HT (lA) receptor binding and anxiety: a [(11) C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 2001;158:1326-1328.
15. MENKES DB, COATES DC, FAWCETT JP. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 1994;32:37-44.
16. WELTZIN TE, FERNSTROM JD, McCONAHA C, KAYE WH. Acute tryptophan depletion in bulimia: effects on large neutral amino acids. Biol Psychiatry 1994;35:388-397.
17. WURTMAN RJ, HEFTI F, MELAMED E. Precursor control of neurotransmitter synthesis. Pharmacol Rev 1980;32:315-335.
18. SHOPSIN B, GERSHON S, GOLDSTEIN M, FRIEDMAN E, WILK S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun 1975;1:239-249.
19. DELGADO PL, CHARNEY DS, PRICE LH, LANDIS H, HENINGER GR. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci 1989;45:2323-2332.
20. DELGADO PL, CHARNEY DS, PRICE LH, AGHAJANIAN GK, LANDIS H, HENINGER GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch General Psychiatry 1990;47:411-418.
21. MILLER HL, DELGADO PL, SALOMON RM, LICINIO J, BARR LC, CHARNEY DS. Acute tryptophan depletion: a method of studying antidepressant action. J Clin Psychiatry 1992;53(Suppl.):28-35.
22. CARPENTER LL, ANDERSON GM, PELTON GH et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998;19:26-35.
23. WILLIAMS WA, SHOAF SE, HOMMER D, RAWLINGS R, LINNOILA M. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 1999;72:1641-1647.
24. DELGADO PL, MILLER HL, SALOMON RM et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999;46:212-220.
25. ABERG-WISTEDT A, HASSELMARK L, STAIN-MALMGREN R, APERIA B, KJELLMAN BF, MATHE AA. Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders. Acta Psychiatr Scand 1998;97:374-380.
26. DELGADO PL, CHARNEY DS, PRICE LH, AGHAJANIAN GK, LANDIS H, HENINGER GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch General Psychiatry 1990;47:411-418.
27. BELL C, ABRAMS J, NUTT D. Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 2001;178:399-405.
28. MILLER HE, DEAKIN JF, ANDERSON IM. Effect of acute tryptophan depletion on CO2 C02-induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 2000;176:182-188.
29. KLAASSEN T, KLUMPERBEEK J, DEUTZ NE, VAN PRAAG HM, GRIEZ E. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res 1998;77:167-174.
30. KOSZYCKI D, ZACHARKO RM, LE MELLEDO JM, YOUNG SN, BRADWEJN J. Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers. Biol Psychiatry 1996;40:648-655.
31. KENT JM, COPLAN JD, MARTINEZ J, KARMALLY W, PAPP LA, GORMAN JM. Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report. Psychiatry Res 1996;64:83-90.
32. GODDARD AW, CHARNEY DS, GERMINE M et al. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry 1995;38:74-85.
33. SCHRUERS K, KLAASSEN T, POLS H, OVERBEEK T, DEUTZ NE, GRIEZ E. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients. Psychiatry Res 2000;93:179-187.
34. GODDARD AW, SHOLOMSKAS DE, WALTON KE et al. Effects of tryptophan depletion in panic disorder. Biol Psychiatry 1994;36:775-777.
35. BELL C, FORSHALL S, ADROVER M et al. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol 2002;16:5-14.
36. NUTT DJ, GLUE P, LAWSON C, WILSON S. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch General Psychiatry 1990;47:917-925.
37. CLARK DM, SALKOVSKIS PM, HACKMANN A, MIDDLETON H, ANASTASIADES P, GELDER M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994;164:759-769.
38. BARLOW DH, GORMAN JM, SHEAR MK, WOODS SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. J Am Med Assoc 2000;283:2529-2536.
39. BECK JG, STANLEY MA, BALDWIN LE, DEAGLE EA III, AVERILL PM. Comparison of cognitive therapy and relaxation training for panic disorder. J Consult Clin Psychol 1994;62:818-826.
40. NEUMEISTER A, KONSTANTINIDIS A, STASTNY J et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch General Psychiatry 2002;59:613-620.